Thymopoietin pentapeptide (TP-5) improves clinical parameters and lymphocyte subpopulations in atopic dermatitis.
Kang, K
Thymopoietin pentapeptide (TP-5) improves clinical parameters and lymphocyte subpopulations in atopic dermatitis. [electronic resource] - Journal of the American Academy of Dermatology Mar 1983 - 372-7 p. digital
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
0190-9622
10.1016/s0190-9622(83)70042-3 doi
Adult
Dermatitis, Atopic--drug therapy
Double-Blind Method
Hormones--therapeutic use
Humans
Immunoglobulin E--metabolism
Leukocyte Count
Lymphocytes--drug effects
Middle Aged
Peptide Fragments--therapeutic use
Thymopentin
Thymopoietins--therapeutic use
Thymus Hormones--therapeutic use
Thymopoietin pentapeptide (TP-5) improves clinical parameters and lymphocyte subpopulations in atopic dermatitis. [electronic resource] - Journal of the American Academy of Dermatology Mar 1983 - 372-7 p. digital
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
0190-9622
10.1016/s0190-9622(83)70042-3 doi
Adult
Dermatitis, Atopic--drug therapy
Double-Blind Method
Hormones--therapeutic use
Humans
Immunoglobulin E--metabolism
Leukocyte Count
Lymphocytes--drug effects
Middle Aged
Peptide Fragments--therapeutic use
Thymopentin
Thymopoietins--therapeutic use
Thymus Hormones--therapeutic use